Prevention of breast cancer with tamoxifen—an update on the royal Marsden Hospital pilot programme
- 1 January 1990
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 26 (6) , 680-684
- https://doi.org/10.1016/0277-5379(90)90116-b
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Chemoprevention of breast cancerBreast Cancer Research and Treatment, 1989
- A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for prevention of breast cancerBritish Journal of Cancer, 1989
- Fasting Specimens Not Required for Routine Measurement of Plasma Apolipoproteins A-I and BAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1989
- Chemoprevention of Breast CancerActa Oncologica, 1989
- Tamoxifen, serum lipoproteins and cardiovascular riskBritish Journal of Cancer, 1988
- Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study.Circulation, 1987
- BLOOD LIPIDS, LIPID-RELATED MEASURES, AND THE RISK OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASEEpidemiologic Reviews, 1987
- THE PREVENTION OF BREAST CANCERThe Lancet, 1986
- Serum lipoproteins and proteins after breast cancer surgery and effects of tamoxifenAtherosclerosis, 1984
- The Epidemiology and Etiology of Breast CancerNew England Journal of Medicine, 1980